Comunicati.net - Comunicati pubblicati - Comune di Ferrara Comunicati.net - Comunicati pubblicati - Comune di Ferrara Mon, 18 Jan 2021 20:50:23 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/1 The Flavors Into Over The Counter OTC Pharmaceuticals Market To Be Resplendent At A CAGR Of 7% Fri, 15 Jan 2021 08:54:33 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html persistencemarketresearch persistencemarketresearch Preference for fruit flavors in medicines is an ongoing trend in the  flavors into over-the-counter (OTC) pharmaceuticals market . The consumption of fruit flavor formulations by leading manufacturers is relatively high as compared to other flavors.

Strong consumer preference for fruit flavors has prompted manufacturers of OTC pharmaceuticals to develop unique formulations using them.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/30665

Company Profiles:

  • Givaudan SA
  • International Flavors & Fragrances Inc.
  • Kerry Group
  • Sensient Technologies Corp.
  • GOLD COAST INGREDIENTS, INC.
  • Prinova Group LLC.
  • Carmi Flavor and Fragrance Co. Inc.
  • AromataGroup srl
  • Marc Flavors
  • Quest Nutra Pharmaceuticals
  • Sapphire Flavors & Fragrances
  • TASTE MASTER FLAVORS PVT LTD.
  • Virginia Dare
  • Concept Flavours & Fragrances Pvt. Ltd.
  • Flavor & Fragrance Specialties

Fruit flavors such as pineapple, strawberry, cherry and orange are mostly preferred flavors for pharmaceuticals. The adoption of flavored pharmaceuticals, especially in medicines for kids, is increasing because of the taste masking effect of these medicines.

Citrus and lemon flavors, followed by fruit flavors, are commonly used by formulators of pharmaceuticals.

Lemon and mint flavors are generally preferred in chewable tablets or gums. Vanilla or other dairy-based flavors are the least preferred flavors, used in medicines.

PMR has also found that the adoption of flavored medicines, among geriatric patients is lesser as compared to those for pediatric patients.

Outsourcing and Industrial Consolidation – Key Winning Imperatives

The report states that the companies manufacturing OTC pharmaceuticals typically focus on volume, and hence have been shown to be involved in several industrial collaborations. Key players in the flavors into over-the-counter (OTC) pharmaceuticals market are focusing on entering into strategic collaborations and acquisitions of companies operating in related industry to strengthen their position and extend their global reach.

For Example, in 2018, Sensient Technologies Corp. completed the acquisition of Mazza Innovation Limited, a botanical extraction business with patented solvent-free extraction processes, located in Vancouver, Canada.

Similarly, in 2017, International Flavors & Fragrances Inc. acquired “David Michael”, a privately held flavor company. Through this acquisition, International Flavors & Fragrances, Inc. strengthened its flavor market position in North America.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30665

Tapping into Opportunities in Developing Countries

Most of the pharmaceutical players are focusing on developing markets, due to the stagnation of the major markets and presence of a large number of local manufacturers, especially in developing countries.

Changes in disease pattern caused due to changes in the lifestyle, increase in disposable income, improved access to healthcare services, and increasing demand for high-quality healthcare make these markets highly profitable for pharmaceutical companies.

However, this trend is currently opposite in developed economies with sophisticated manufacturing practices, where demand for superior quality excipients is increasing.

An increase in the adoption of continuous processing of excipients, is also an ongoing trend in flavors into the over-the-counter (OTC) pharmaceuticals market. Continuous processing of excipients refers to flow production of the raw material without any kind of interruption.

Manufacturers Target towards Production Capacity Expansion

Over the past few years, major pharmaceutical companies have been expanding their external and internal capacity in production.

Outsourcing opportunities arise in all innovator, generic, as well as other markets for OTC medications.

Even though manufacturing technologies for OTC medications have rapidly matured in the past two decades, the manufacturing of low-margin OTC generics requires the usage of old technologies.

While major pharmaceutical companies are investing resources on newer technologies, the manufacturing of generic OTC drugs and branded over-the-counter drugs is being outsourced.

South Asia & East Asia Remain Prominent Markets

South Asia and East Asia are expected to show significant growth of the flavors in over-the-counter (OTC) pharmaceuticals market. A large portion of the population of Asia remains undertreated, majorly due to the unavailability of effective prescribed drugs, and this is providing growth opportunities for the flavors into over-the-counter (OTC) pharmaceuticals market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/30665

Low Awareness and Poor Availability of OTC Drugs to Hinder the Market Growth

Lack of awareness about the flavors into OTC pharmaceuticals, especially in the developing economies, continues to create a hindrance in the market growth.

Poor availability of drugs at hospital pharmacies and retail pharmacies can be responsible for decreasing the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market. Also, the marketing of OTC pharmaceutical products requires skilled, trained and knowledgeable pharmacists. A lack of skilled and trained pharmacists, especially in the developing regions, can hinder the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market.

]]>
The Global Scar Treatment Market To Grow At A Splendid CAGR Of 3% Fri, 15 Jan 2021 08:54:10 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) reveals that revenue generated from scar treatment product during financial year 2019 is approximately more  than US $ 10 Bn . According to the report published by PMR, reveals that the  scar treatment market  is anticipated to  show 1.4X growth  over the next decade owing to greater preference towards usage of specialized dermatology services.

This report by PMR points to the lack of standardization in the scar treatment landscape. The study reveals that there are no formalized guidelines for scar treatment, and most of them are recommended through word-of-mouth of expert clinicians and surgeons. However, efforts for the formalization of treatment guidelines, at least for common scars, still continue.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10819

Company Profiles:

  • Smith & Nephew PLC
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Rising Awareness about Personal Care Propelling the Demand

Scars, especially those on exposed parts of the body can adversely affect the appearance and may let down the self- confidence and consciousness of an individual. Consumers in the U.S. are more inclined towards new sophisticated scar treatment, such as lasers skin resurfacing, electrical stimulation, and derma fillers to maintain and further reduce scar appearance.

Expert plastic surgeons opine that a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, is increasingly resorting to advanced skin, scar, and dermatology services, thus, creating sufficient traction for scar treatment product manufacturers.

Rising awareness about personal care and wide availability of rhytides treatment and related products are among the major factors driving growth of the scar treatment market in North America and Europe.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10819

Patients Seek Quicker Results and Shortened Treatment Duration

Patients opting for scar treatment are increasingly adopting technologically advanced non-invasive or minimally invasive scar treatment procedures for achieving quicker and permanent results in a short time. To address this issue, physicians are gradually seeking more patient-involvement in the scar treatment formulation process.

For example, in developed countries, physicians prefer to explain the indication / s and different scar treatments that could help in curing them - to patients on the very first consultation appointment.

For example, a combination of inflammatory and non-inflammatory acne pimples could be best-cured using two topical medications - a retinoid and an antibiotic, an option for scar treatment. Managing patient expectation is a crucial attribute on part of both physicians and companies to deepen revenues.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/10819

Increasing Patient Involvement in Treatment Formulation Process

With heightened focus towards increasing patient safety and treatment efficacy, an increasing number of dermatologists in both the US and Canada are involving patient's opinion in the scar treatment formulation process.

This is being particularly noted for patients aged 13–25 years (teens to late teens), particularly for mild to deep acne scarring. In this regard collected, scar treatment adherence data over a period of 30 years from Global Alliance to Improve Outcomes in Acne Group reflected poor results while managing the acne regimen.

Deviations noted include self-medication, missing doctor appointment schedules, or both. These were directly a result of combination of multiple factors, including demographics, lifestyle, psychological / psychiatric issues, and environment.

Given these issues, physicians and clinicians have noted that greater patient involvement in therapeutic planning process along with increasing awareness of patients by imparting proper training have been proving highly effective with regard to positive outcomes for scar treatment.

]]>
The Urinary Catheters Market To Leave Behind Presumptions With An Estimated CAGR Of 4.1% Fri, 15 Jan 2021 08:53:48 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html persistencemarketresearch persistencemarketresearch Global revenue of urinary catheters reached ~  1.5 billion  in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report,  the urinary catheters market  is estimated to grow  by ~ 4% YOY in 2019 , primarily attributed to ease of use, cost effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favored for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc.
  • Hollister Incorporate
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

According to the report, increasing focus on advanced urinary catheters coated with hydrogel, teflon, silicon, elastomer, etc., is rising owing to increasing concern of regulatory bodies across all regions to reduce the infection during catheterization process.

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity.

Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3268

The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery.

Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3268

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters.

In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market.

A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~ 4%. Accounting for ~ 23%  share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.

]]>
The Pyrogen Testing Market To Take A Parabolic Turn With A CAGR Of 9% Fri, 15 Jan 2021 08:53:26 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html persistencemarketresearch persistencemarketresearch The new market intelligence report by Persistence Market Research (PMR) reveals that the  global pyrogen testing market  will  reach US $ ~ 800 Mn  by the end of 2019, and further exhibit a  robust CAGR of 9%  through the next decade.

The increasing trend of outsourcing drug manufacturing to low-cost production regions by most pharmaceutical companies has been touted to remain a major influencer associated with the growth of pyrogen testing market landscape over the period of assessment, as it allows for low-cost skilled workforce and ease in tax relaxation.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/4259

Company Profiles:

  • Thermo Fisher Scientific, Inc.
  • Merck & Co., Inc.
  • Associates of Cape Cod, Inc.
  • Charles River Laboratories, Inc.
  • GenScript
  • Lonza
  • Hyglos GmbH
  • Wako Chemicals USA, Inc.
  • Microcoat Biotechnologie GmbH

Growing Number of Pharmaceutical and Biotechnology Companies to Bring Traction to Pyrogen Testing

As medical devices cross the barriers within the body leading to contamination, pyrogen testing could be used by healthcare professionals to detect the harmful substances present in those devices. In addition, growing healthcare awareness also leads to upsurge in the medicine demand, which increases establishment of pharmaceuticals and biotechnology industries.

This in turn, propels the demand for pyrogen testing in these establishments worldwide. Moreover, increase in number of people diagnosed with various diseases results in the rising demand for various injectables, vaccines, tablets, and other medicines in turn, fueling the demand for safety measures such as pyrogen testing.

According to the PMR analysis, in end user, pharmaceutical companies will dominate the demand side in the pyrogen testing market by the end of 2019 and will also continue to exploit the highest share in the forecast period.

This is due to the growing number of pharmaceutical establishments in developed as well as developing countries, which increases the need for drug safety checks like pyrogen testing.

Demand for limulus amebocyte lysate (LAL) pyrogen testing is estimated to grow by the end of 2029, as end users demands for user-friendly pyrogen testing method that are cost-effective, and incur low equipment cost as well. Thus, the PMR study report estimates that LAL pyrogen testing method will harness around 60% of the global pyrogen testing market share during the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4259

Favorable Government Initiatives to Augur Well for Pyrogen Testing Market

Increasing spending by government bodies to develop effective drugs and medical devices is expected to drive the growth of the global pyrogen testing market in the forecast period. Pyrogen is a prominent cause that leads to shock or fatality among a large section of the patient population creating an economic burden on the country.

Thus, increasing healthcare spending is expected to result in growing demand for pyrogen testing by various pharmaceutical and medical device companies. Also, government in various countries are focused on of infectious diseases to reduce associated healthcare costs, which in turn prevention is expected to result in high demand for healthcare facilities.

In order to further complement this, government is focusing on pyrogen testing policies for contaminant-free medical devices and pharmaceuticals provided to the patient population, which will pave the way for the elevated requirement of pyrogen testing in the market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/4259

Hence, companies operating in the pyrogen testing market are expected to largely benefit from such developments.

PMR's analysis also projects groundbreaking perspectives on the competitive business scenario of the pyrogen testing market along with highlights of participants' key business policies and approaches.

For instance, many drug manufacturing units are investing in foreign nations, especially in emerging economies of Asia Pacific and Latin America, which hold great future opportunities for the pyrogen testing market. Various pharmaceutical and medical device manufacturers are establishing their manufacturing base in India, China, and others in order to tap and cater to the unmet needs of the patient population in these regions, thus escalating the market for pyrogen testing.

]]>
The Ultrasonic Skin Care Devices Market To Grow Organically At A CAGR Of 5% Fri, 15 Jan 2021 08:53:04 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) published a report on the ultrasonic skin care devices market, which considers the global industry analysis 2014 - 2018 and opportunity assessment 2019 - 2029, and projects that  the ultrasonic skin care devices market  is expected to reach ~  US $ 440 Mn  by the end of 2019 in terms of value, and is forecasted to reach ~  US $ 720 Mn  by the end of 2029.

The presence of large number of companies is creating a healthy environment among the players. Companies with wide range of ultrasonic skin care devices are creating competitive environment for the other players in the market. The players are constantly working on developing better products to stay ahead of the pack.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27490

Company Profiles:

  • Merz Pharma GmbH & Co. kGaA
  • Koninklijke Philips N.V
  • Iskra Medical d.o.o
  • Ibramed
  • Shenzhen Leaflife Technology Co., Ltd
  • Guangzhou Beautylife Electronic Technology Co., Ltd.
  • Ionto Health & Beauty Gmbh
  • Grand Aespio Inc.
  • Termosalud S.L
  • Adore cosmetics
  • Hironic Co. Ltd.
  • Bomtech Electronics co., Ltd
  • General Project Srl
  • Asterasys Co. Ltd.
  • Jellen Products Inc.

Companies such as Merz Pharma GmbH & Co. KGaA, Adore Cosmetics, Jellen Products, Inc. etc. are some of the prominent players in the market. Presence of local players including Shenzhen Bowei tech Co.ltd, Zerone Co., Ltd., and others are further likely to challenge the established companies.

Thus, these conditions are inciting manufacturers to come up with more advanced and improvised ultrasonic skin care devices.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27490

Manufacturers to Tap Opportunities in Sales through E-commerce Sites

The online availability of the ultrasonic skin care devices has created a favorable condition for the market players. Most of the companies provide the international shipping services, and therefore the devices can be ordered from anywhere globally.

Many products are also available on online shopping sites such as amazon, flipkart, etc. and can be easily purchased by consumers, even in remote areas. These online websites also help in brand promotion and advertisement of ultrasonic skin care devices, thereby creating better opportunities for players.

Increasing Adoption of Home-based Skin Care Devices to Push the Market Growth

There is high demand for home care setting ultrasonic skin care devices which are user friendly and convenient to use. These ultrasonic skin care devices are cost effective and do not require any extra maintenance. Also, the procedure time for home care ultrasonic skin care devices are shorter as compared to table top devices and do not require professionals to operate.

Products such as palm sonic by Adore Cosmetics, Visa boost by Philips, PureCle Dr. by Bomtech Electronics co., Ltd. continue to account major share of the manufacturers' bottom lines. Home- based devices are easy to handle and do not require any professional assistance. These devices can be used for various applications such as skin tightening and skin rejuvenation, with better results.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/27490

Table top devices are used in hospitals and clinics, and require professional experts to operate them. The ultrasonic skin care tabletop devices are widely used to overcome several skin related problems and to perform certain procedures like face lifting, skin tightening etc.

However, the cost of these ultrasonic skin care devices are high as compared to other handheld devices, thus representing a threat to the market growth. For instance, Ultherapy ultrasonic device manufactured by Merz Pharma GmbH & Co. KGaA are widely used in aesthetic clinics and has average price of  US $ 70000 . Such high cost of these devices are likely to act as a hindrance for the growth of the ultrasonic skin care devices market.

]]>
The Pulmonary Fibrosis Treatment Market To Witness A Steep CAGR Of Double In% Fri, 15 Jan 2021 08:52:42 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683679.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683679.html persistencemarketresearch persistencemarketresearch Globally, increasing diagnosis rate for the pulmonary fibrosis is expected to drive the growth of the pulmonary fibrosis treatment market. According to the latest research by the company, the  global pulmonary fibrosis treatment market  is projected to account for a market value of  ~ US $ 4.4 Bn by the end of 2029 . The report also projects significant growth potential for the pulmonary fibrosis treatment market throughout the forecast period.

Increasing diagnosis rate of the pulmonary fibrosis due to enhanced understanding of the disease is the prime driver of the pulmonary fibrosis treatment market. Although the disease understanding and understanding of the associated symptoms has advanced immensely, misdiagnosis still remains as high as 40% in developed regions, potentially hampering the growth of the pulmonary fibrosis treatment market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/30070

Company Profiles:

  • Genentech, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Alkem Laboratories Ltd.
  • Alniche Life Sciences Pvt Ltd
  • MHS Pharmaceuticals
  • Torrent Pharmaceuticals Ltd
  • Anthem Biopharma Pvt Ltd
  • Panacea Biotec
  • Zydus Healthcare Ltd
  • Nuper Therapeutics
  • Fresenius Kabi India Pvt Ltd.
  • Sun Pharmaceutical Industries Ltd

Increasing literature about the pulmonary fibrosis treatment, causes and increasing small and medium sized regional studies by universities, pulmonary fibrosis organizations are assisting to improve the overall awareness about the disease in the general population.

The similarities of symptoms of pulmonary fibrosis with other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, etc. are the major impediments in the precise diagnosis of the disease delaying the pulmonary fibrosis treatment.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30070

Combination Drug Therapies

Corticosteroids, coupled with immunosuppressants and chemotherapeutic agents, were the only treatment available for the pulmonary fibrosis till the drugs such fibrosis Ofev (nintedanib) and Esbriet (pirfenidone) approved for the pulmonary fibrosis treatment in 2014. 

Both drugs slow disease progression by slowing down the lung tissue scarring. Patients treated with monotherapy of these drugs or combination therapy of these drugs along with corticosteroids or immunosuppressants has given healthcare professionals pulmonary fibrosis treatment options for the effective management of the disease.

Various new therapies are being evaluated by pharmaceutical and biopharmaceutical companies for the possible pulmonary fibrosis treatment.

Orphan drug designation reduces drug development cost considerably in turn encouraging pharmaceutical and biopharmaceutical companies to develop drugs for the treatment of rare diseases such as pulmonary fibrosis. Companies that received the orphan drug designation for their products for pulmonary fibrosis treatment benefitted from protocol assistance, marketing authorization, financial incentives, and national incentives provided by the European Commission.

The FDA orphan drug designation programs offer a unique status to biologics and drugs intended to pulmonary fibrosis treatment, diagnose, and prevent diseases in the US The FDA orphan drug designation offers an exclusivity period of seven-year marketing for competition and certain incentives including tax credits , federal grants, and a waiver of PDUFA filing fees .

Access Full Report @  https://www.persistencemarketresearch.com/checkout/30070

In August 2019 , Daewoong Pharmaceutical received orphan drug designation from UFDA for its DWN12088, oral IPF therapy.

The company has segmented the global pulmonary fibrosis treatment market based on the therapy type, indication, distribution channel, and region. In terms of revenue, the monotherapy segment by therapy type is expected to be a prominent segment in pulmonary fibrosis treatment market over the forecast period.

By indication, the idiopathic pulmonary fibrosis (IPF) segment of the pulmonary fibrosis treatment market is expected to generate highest revenue during the forecast period due to higher prevalence of the disease type. By distribution channel, the pulmonary fibrosis treatment market is expected to be dominated by the retail sales segment due to higher patient footfall.

By region, the North America pulmonary fibrosis treatment market is expected to be a prominent region in the global pulmonary fibrosis treatment market.

]]>
The Skin Barriers Market To Move Away From Stagnation, Reach US$ 465 Million Thu, 14 Jan 2021 09:22:04 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683528.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683528.html persistencemarketresearch persistencemarketresearch The  skin barriers market  is a niche market, and is a consolidated space with many major players. The parent market for skin barriers is incontinence and ostomy. Skin barriers generally fall under accessory products offered by companies to complement healing and facilitate skin protection. The potential of the skin barriers market has not yet been fully tapped because of products being less focused on and marketed.

The ongoing  COVID-19  pandemic is expected to have limited impact on the global skin barriers market. Ostomy procedures and medical diagnosis of incontinence are being postponed due to more pressing needs related to coronavirus. However, due to lockdown conditions, the online sales channel is expected to aid market growth.

Persistence Market Research estimates that the global skin barriers market is set to witness a CAGR of 4% over the forecast period (2020-2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/28816

Companies covered in Skin Barriers Market Report

  • ConvaTec Inc
  • Hollister Inc
  • DermaRite Industries LLC
  • 3M
  • Coloplast Corp
  • Stryker
  • Integra Lifesciences Corp
  • Smith & Nephew
  • GOJO Industries
  • Medline Industries
  • B Braun Melsungen AG
  • Sonoma Pharmaceuticals Inc
  • Welland Medical Ltd.
  • Essity

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/28816

Key Takeaways from Skin Barriers Market Study

  • By product, skin barrier sprays are expected to be the most lucrative segment in the global skin barriers market by the end of 2030.
  • By indication, incontinence and ostomy will witness a growth of almost 1.5 times from the year 2020 to 2030.
  • The institutional sales channel is expected to hold more than 50% of market share by the end of 2030.
  • By region, North America is estimated to be the most attractive region in the global skin barriers market, expanding at a CAGR of 4.4%.
  • Countries such as China, Japan, India, and South Korea have the potential to drive future growth of the skin barriers market, owing to growing burden of incontinence and increasing awareness about the condition in these regions.

There is growing trend of homecare services such as short-term nursing services and other professional aides for the elderly to help them live independently. Elderly are the most common group suffering from incontinence, which is a major reason of using skin barrier products.

“Advancements in incontinence products coupled with increasing e-Commerce sales during the COVID-19 pandemic will propel the growth of the global skin barriers market,”  proposes a PMR analyst.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/28816   

Ease of Use, Portability, & Effectiveness Remain Key Reasons Driving Demand for Skin Barrier Sprays

Skin barrier sprays are the most lucrative segment in the global skin barriers market, with an estimated market share of almost  30%  by the end of  2030 . Ease of usability provided by skin barrier sprays in terms of early drying on the skin, and thereby non-transferability on garments, and non-sticky consistency, are some of the advantages provided by sprays.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the skin barriers market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 , on the basis of product (skin barrier sprays, moisture barrier creams, protective ointments, and others) indication (incontinence and ostomy, chronic wounds, pressure ulcers, skin rash & dry skin, and atopic dermatitis), and distribution channel (institutional sales [hospitals, specialty clinics, long-term care centers, and skilled nursing facilities ] and retail sales [retail pharmacies, drug stores, and online sales]), across seven key regions.

]]>
The Alginate Dressings Market To Witness A Stunning Progression, Reach US$ 1.1 Billion Thu, 14 Jan 2021 09:21:42 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683527.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683527.html persistencemarketresearch persistencemarketresearch Wound dressing plays a crucial role in healing and management. Alginate dressings are the most preferred products to treat pressure ulcers, leg ulcers, infected surgical wounds, etc. which has led to a surge in their demand. Besides, introduction of new alginate dressing products with better functionalities by market players has also aided market growth. Increasing investments in new alginate dressing development and growing efforts for their distribution by key stakeholders are major factors expected to boost the growth of the alginate dressings market.

The global  alginate dressings market  is projected to be valued at  US $ 1.1 Bn in 2030 , and is expected to exhibit a  CAGR of 3.5%  during the forecast period  (2020 - 2030) .

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/26929

Companies covered in Alginate Dressings Market Report

  • 3M Co
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/26929

Key Takeaways from Alginate Dressings Market Study

  • Antimicrobial alginate dressings contributed for a larger revenue share than non-antimicrobial alginate dressings in the global alginate dressings market in 2019, owing to their high preference of use for wound healing.
  • High adoption of alginate dressings for the treatment chronic wounds is expected to result in notable market share of the chronic ulcers segment in the alginate dressings market.
  • Institutional sales contributed around three-fourth of value share by distribution channel due to increasing patient preference.
  • North America captured a greater revenue share among all regions, and is expected to be the most lucrative region in the global alginate dressings market during the forecast period.
  • Reluctant adoption and high cost of products are factors expected to affect the growth of the alginate dressings market around the globe.
  • Outbreak of the  COVID-19  pandemic has had a moderate impact on the overall growth of the alginate dressings market, due to its adverse effect on the global economy and healthcare industry.

Increasing prevalence of chronic and traumatic wounds and continuous focus of key market players to develop advanced wound dressing products are projected to propel the global alginate dressings market over the coming years, ”  says a PMR analyst.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/26929

Consolidation Activities: Imperative Strategy for Market Players

Increase in market consolidation activities by market players, including collaborations and partnerships, are characteristics of the overall competition among global alginate dressings market players. Manufacturers are focusing on collaborations with research institutes and universities to drive research & development in advanced wound care. For instance, in July  2017 , Smith & Nephew collaborated with the University of Hull to drive research in the field of advanced wound care.

What else is in the report?

Persistence market research offers actionable insights and a unique perspective on the alginate dressings market, in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for 2020–2030, based on alginate dressing type (antimicrobial alginate dressings and non-antimicrobial alginate dressings), indication (chronic ulcers and non-healing surgical wounds), and distribution channel (institutional sales and retail sales), across seven key regions.

]]>
The Nitrile Gloves Market To Stabilize Post Stumbling Amidst Covid-19, Reach US$ 26.7 Billion Thu, 14 Jan 2021 09:21:19 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683526.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683526.html persistencemarketresearch persistencemarketresearch The growing pandemic of community infections owing to the emergence of new pathogens is expected to increase the demand for nitrile gloves across the world. The need to quell community and hospital-acquired infections is expected to drive the growth of the global nitrile gloves market.

Key product manufacturers operating in the market offer a wide range of products, such as disposable and reusable nitrile gloves. Owing to the non-availability of treatment for new pathogen infections and significant lag phase between the emergence of new pathogens and development of effective treatment and vaccines, there has been increasing need for nitrile gloves as a preventive measure.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/31892

Companies covered in Nitrile Gloves Market Report

  • Cardinal Health
  • Kimberly Clark Corporation
  • Top Glove Corporation Berhad
  • Dynarex Corporation
  • Ansell Limited
  • Adventa Berhad
  • Rubberex Corporation
  • 3M Company
  • Kossan Rubber Industry Ltd.
  • Hartalega Holdings Berhad
  • Supermax Corporation Berhad
  • Medline Industries, Inc.
  • B. Braun Melsungen AG

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/31892

Persistence Market Research predicts that the global nitrile gloves market will exhibit an impressive CAGR of 24% during the forecast period (20202030), to be valued at US$ 26.7 Bn by 2030-end.

Key Takeaways from Nitrile Gloves Market Study

  • By product type, powder-free gloves are expected to gain traction in the global nitrile gloves market during the forecast period.
  • Owing to the use of powder-free gloves for the prevention of primary infections and allergic side-effects, and to perform surgical procedures, the powder-free segment is the most dominating product type in North America and Europe nitrile gloves markets.
  • In terms of usage, disposable gloves are expected to gain more than 1/3 share in the nitrile gloves market share by 2030.
  • By sterility, sterile gloves are expected to hold more than 1/3 revenue share in the global nitrile gloves market by 2030, owing to high standard regulatory compliance requirements for medical nitrile gloves.
  • Under the end user segmentation, hospitals and ambulatory surgical centers segments are expected to collectively gain more than 2/3 market share in the nitrile gloves market by  2030 .
  • North America is the highest revenue generating market by region, due to the high rate of  COVID-19  pathogenic infections and 10X increase in the average selling prices of nitrile gloves. Europe is expected to offer lucrative opportunities, owing to higher incidence of hospital-acquired infections and increasing volume of innovative surgical procedures.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/31892

"Disruptive unmet demand for medical gloves with 10X rise of average selling price, and WHO pushing for effective COVID-19 prevention, are expected to propel the growth of the global nitrile gloves market,"  says a PMR analyst.

Accelerated Expansion & Acquisition by Leading Industry Players to Meet Unmet Demand in Nitrile Gloves Market

Leading manufacturers in the global nitrile gloves market are extensively focusing on the expansion of their manufacturing capabilities due to current disruptive demand. Governments are actively encouraging local manufacturers to prioritize emergency demand, specifically for public hospitals and healthcare setups.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the nitrile gloves market, in its latest study, presenting historical demand assessment of  2015  -  2019  and projections for  2020  -  2030 , on the basis of product type (powder-free gloves and powdered gloves ), usage (disposable gloves and reusable gloves), sterility (sterile gloves and non-sterile gloves), and end user (hospitals, ambulatory surgical centers, clinics, diagnostic centers, and others) across seven key regions.

]]>
The Peptic Ulcer Drugs Market To Slide Amidst Covid-19 With US$ 40,004.3 Million Thu, 14 Jan 2021 09:20:57 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683525.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683525.html persistencemarketresearch persistencemarketresearch Surge in the consumption of NSAIDs due to growing prevalence of inflammatory diseases is the major factor driving the growth of the global peptic ulcer drugs market. Other trends driving growth include increasing adoption of peptic ulcer drugs over surgery, changes in disease management, prevalence of stress ulcers due to higher smoking rates, availability of affordable therapy due to improvements in the service sector, and increasing awareness toward disease management through government campaigns . However, chronic side-effects associated with the long-term use of peptic ulcer drugs is a factor hampering the growth of the global peptic ulcer drugs market to some extent.

As per PMR analysis, the global peptic ulcer drugs market is set for steady growth over the next ten years, to be valued at US$ 47.7 Bn by 2030-end.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3704

Companies covered in Peptic Ulcer Drugs Market Report

  • Pfizer Inc.
  • Abbvie Inc.
  • GlaxoSmithKline plc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Daewoong Pharmaceutical Co., Ltd.
  • Takeda Pharmaceutical
  • Eisai Co. Ltd.
  • Cadila Healthcare Ltd.
  • Yuhan Corporation

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3704

Key Takeaways from Peptic Ulcer Drugs Market Study

  • By product, the proton pump inhibitors segment was the largest revenue generating segment in the historical years. However, revenue from the potassium-competitive acid blockers segment is expected to expand rapidly, owing to the introduction of new P-CAB drugs in the market.
  • Based on indication, the gastric ulcers segment is anticipated to expand at the highest CAGR of 3% over the forecast period.
  • On the basis of distribution channel, the hospital pharmacies segment led the global peptic ulcer drugs market, and is expected to remain the leading segment ahead too. Increasing hospitalization rates due to ulcer complications are expected to be the primary factor fuelling revenue growth of the segment over the forecast period.
  • North America holds the largest share in the global peptic ulcer drugs market, followed by Europe and East Asia.
  • Due to the worldwide  COVID-19  outbreak, physician and hospital visits for non-essential treatment have reduced considerably, putting breaks on the progress of the peptic ulcer drugs market space.

"Increasing NSAID consumption is the major boosting factor for the growth of the global peptic ulcer drugs market,"  says a PMR analyst.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3704

Peptic Ulcer Drugs  Market: Competition Analysis

Key players operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals Ltd. These companies are primarily focusing on strategies such as co-promotions and co-marketing of their brands to penetrate the fastest-growing emerging markets across the world.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the peptic ulcer drugs market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 . Research of this report has been done based segmentation into product, indication, and distribution channel, across seven key regions of the world.

]]>
The Urothelial Carcinoma Diagnostics Market To Flicker Amidst Covid-19, Reach US$ 1 Billion Thu, 14 Jan 2021 09:20:35 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683524.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683524.html persistencemarketresearch persistencemarketresearch According to World Health Organization (WHO) estimates, every year,  3.8 Mn  new cases of urothelial carcinoma occur around the world, with the recurrence rate being nearly  30-50% . However, early detection by use of modern diagnostics enables quick medical decision-making and consequent treatment for urothelial carcinoma. Accuracy in urothelial carcinoma diagnosis plays a significant role in the reduction of treatment costs.

Moreover, increased demand for treatment of urothelial carcinoma is a key driver for increasing revenue inflow from diagnostic tests and procedures. However, development of effective urothelial carcinoma screening methods will play a significant role in the early detection and subsequent reduction in mortality rates. Furthermore, technological advancements in diagnostic methods such as the adoption of diagnostic imaging procedures, rapid molecular diagnostic kits, and use of biomarker testing in urothelial carcinoma screening programs are some other factors that will aid the growth of the urothelial carcinoma diagnostics market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14128

Companies covered in Urothelial Carcinoma Diagnostics Market Report

  • GE Healthcare
  • Roche Holding
  • Illumina
  • IDL Biotech
  • Agilent Technologies
  • Olympus Corporation
  • Philips Healthcare
  • Abbott Molecular
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc.( Qiagen N.V.)
  • Danaher Corporation (Cepheid)

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14128

According to the latest report published by PMR, the global urothelial carcinoma diagnostics market was valued at US$ 1 Bn in 2020, and is expected to progress at a CAGR of over 11% during the forecast period (20202030).

 Key Takeaways from Urothelial Carcinoma Diagnostics Market Study         

  • The reagent and kits segment, under product type, is expected to contribute more than 70% of revenue share in the urothelial carcinoma diagnostics market.
  • By test type, molecular diagnostic tests accounted for the highest revenue in 2019. Rapid and sensitive detection is anticipated to drive demand for urothelial carcinoma diagnostics.
  • Based on end user, the hospitals segment accounts for a major revenue share in the urothelial carcinoma diagnostics market.
  • Leading players launching rapid diagnostic products with advances technology are expected to dominate the urothelial carcinoma diagnostics market space.
  • Governments of various countries are organizing cancer screening programs and are spreading awareness, which is creating significant demand for urothelial carcinoma diagnostics.
  • The  COVID-19  outbreak has resulted in manufacturing disruptions and also decreased demand, which is projected to impede market growth in the near term.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/14128

"Rise in prevalence of urothelial carcinoma and demand for early detection  for preventive treatments will boost the global urothelial carcinoma diagnostics market,"  says a PMR analyst.

Acquisitions and Partnerships - Key Strategies amongst Market Players

Key players in the urothelial carcinoma diagnostics market are looking forward to strengthening their product portfolios through the launch of new products. For instance, in  2017 , Roche received FDA approval for the complementary PD-L1 (SP263) biomarker test in urothelial carcinoma. In  August 2018 , Agilent Technologies, Inc announced that the US Food and Drug Administration approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use as a companion diagnostic test for Merck's anti-PD1 immunotherapy Keytruda (pembrolizumab) for urothelial carcinoma.

Various players in the urothelial carcinoma diagnostics market are focusing on growth strategies such as acquisitions and partnerships. For example, in  2020 , Thermo Fisher Scientific signed an agreement with Janssen to co-develop companion diagnostics for cancer.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the urothelial carcinoma diagnostics market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2020 , on the basis of product type (reagents and kits, instruments), test type (urinalysis test, molecular diagnostic test, biomarker test, imaging test, cytoscopy, ureteroscopy), and end user (hospitals, diagnostic laboratories, research and academic institutes, clinical research organizations), across seven key regions.

]]>
The Advanced Wound Dressing Market To Witness A Slump, Reach Merely US$ 8 Billion Thu, 14 Jan 2021 09:20:13 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683523.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683523.html persistencemarketresearch persistencemarketresearch Rising prevalence of chronic and surgical wounds across the world has led to a surge in the demand for advanced wound dressing procedures. Besides, the introduction of new advanced wound dressing products with better functionalities has also aided market growth. These is growing demand for advanced wound dressing products over traditional dressing products for the treatment of chronic wounds.

Increasing investments in new advanced wound dressing product development and growing efforts for their distribution by key stakeholders are major factors expected to surge the growth of the advanced wound dressing market. The global  advanced wound dressing market  is projected to exhibit a CAGR of  3.5%  during the forecast period ( 2020 - 2030 ).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31673

Companies covered in Advanced Wound Dressing Market Report

  • Ethicon Inc. (Sub. of Johnson & Johnson)
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • 3M Co
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care
  • Medline Industries Inc

Key Takeaways from Advanced Wound Dressing Market Study

  • Based on product type, the foam dressing segment contributed the highest market share of around 27% to the global advanced wound dressing market in 2019, owing to their potential use in the treatment of chronic wounds.
  • Growing prevalence of chronic diseases around the globe and high adoption of the advanced wound dressing for their treatment are expected to result in a notable market share of the chronic ulcers segment in the advanced wound dressing market.
  • Institutional sales, including hospitals, clinics, ambulatory surgical centers, and long-term care centers, hold around three-fourth of value share in the advanced wound dressing market, due to their high service and increasing patient preference.
  • North America holds the highest revenue share of 43%, and is expected to be the most lucrative region in the global advanced wound dressing market during the forecast period.
  • Reluctant adoption and high cost of the products are factors expected to affect the growth of advance wound dressing, to a certain extent, across the globe.
  • The  COVID-19  pandemic will have a mixed effect on the advanced wound dressing market. While non-essential hospital procedures have been put off, those requires advanced wound care dressing will remain in place, thereby aiding market growth to a certain degree.

"Increasing preference of advanced wound dressing products for the treatment of chronic ulcers by clinicians, and continuous focus on the development of advanced wound dressing products with new functionalities by manufacturers, are projected to propel the growth of the global advanced wound dressing market over the coming years, ”  says a PMR analyst.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/31673

Launching New Products - Imperative Strategy for  Market Players

Introduction of new innovative products as per patient needs is a major factor responsible for intense competition among market players in the global advanced wound dressing market. Several companies are focusing on launching versatile advanced wound dressing products to increase their product sales and expand their market share. For example, in  February 2019 , GEMCO Medical launched its GEMCORE360 brand of advanced wound dressing products, which includes foams, alginates, hydrocolloids, and thin-film dressings.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the advanced wound dressing market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 , based on product type (hydrogels dressing, alginate dressings, semi-permeable film dressings, foam dressings, collagen dressings, hydrocolloid dressings, contact layers, super absorbent dressings, and hydrofibers), indication (chronic ulcers and non-healing surgical wounds), and distribution channel (institutional sales and retail sales), across seven key regions .

]]>
The Sterile Injectable Drugs Market To Take An Elliptical Plunge Between 2025 Wed, 13 Jan 2021 14:37:03 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683445.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683445.html persistencemarketresearch persistencemarketresearch According to the recent market research report published by Persistence Market Research titled  ' Sterile Injectable Drugs Market : Global Industry Analysis (2012-2016) and Forecast (2017-2025)' , the global sterile injectable drugs is expected to expand at a significant CAGR 6.9 % during the forecast period 2017–2025.

Persistence Market Research has delivered key insights and presented a revised forecast of the global  sterile injectable drugs market  for a period of 8 years from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based factors driving the demand, as well as the recent developments of key market participants.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/20761

Company Profiles

  • Baxter International Inc.
  • Sanofi
  • GlaxoSmithKline plc.
  • AstraZeneca Plc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • GILEAD SCIENCES, INC.
  • Johnson & Johnson Services, Inc.
  • hameln group gmbh

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/20761

The global sterile injectable drugs market is projected to expand at a moderate CAGR of 6.9%, in terms of value, during the forecast period. The global market is estimated to reflect a valuation of around US$ 655 Mn by 2025 from a value of about US$ 383 Mn in 2017.

Global Sterile Injectable Drugs Market: Segmentation Analysis

The global sterile injectable drugs market is segmented based on molecule type, drug type, applications, route of administration, distribution channel and region.

On the basis of molecule type, the market is segmented into small molecules and large molecules. Large molecules have the highest demand owing to the higher response rate of in sterile injectable drugs. Increased demand for easy to handle unique drug delivery system of injectable drugs, primarily that cater to self-administration of medicines is fuelling demand for sterile drugs market. The driver is prominent in countries that have exorbitant caregiving charges such as Nordics, Germany, and the U.S.

Based on  drug type  the market is segmented as monoclonal antibodies (mAbs), cytokines, insulin, peptide hormones, vaccines, immunoglobulins, blood factors, peptide antibiotics and others. Others drug type segment is expected to have the highest demand due to the higher utilization rate in sterile injectable drugs such as opioid analgesics, general and local anesthetics etc.

Based on  application , the market is segmented into cancer, diabetes, cardiovascular diseases, musculoskeletal, CNS, infections and others. Others application type segment is expected to have the highest market share. Cardiovascular diseases segment is projected to be the fastest growing segment and expected to register a CAGR of 9.2% throughout the period of forecast.

Based on  route of administration  the market is segmented as intravenous, intramuscular (IM), Subcutaneous (SC) and others. Intravenous is the most common route of administration of sterile injectable drugs. The intravenous route of administration is largely adopted and this segment is thus expected to lead the market with a high market valuation and growth rate.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/20761

Based on  distribution channel  the market is segmented in to hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies is said to hold major market share and registering CAGR of 7.2% in terms of value, over the forecast period owing to the increasing focus of availability. The online pharmacies segment is poised to be the fastest growing segment in the coming years.

On the basis of  region , the market has been segmented into North America, Latin America, Europe, Asia-Pacific, and the MEA. North America region dominated the sterile injectable drugs which is estimated to measure around 35% of the global market in 2016 and is expected to continue to dominate the overall market, partly due to the high awareness for self-administration of injectable drugs and entry of players into the market by launching different products.

Conducive business environment in emerging markets such as Asia Pacific and surge in local production of generic injectable are the factors responsible for the highest growth of Asia Pacific sterile injectable drugs market. It is projected to register a high  CAGR of 8.9%  throughout the period of forecast.

]]>
The Cloudbased Drug Discovery Platform Market To Transcend The Covid-19 Barrier From 2025 Onwards Wed, 13 Jan 2021 14:36:40 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683444.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683444.html persistencemarketresearch persistencemarketresearch A new report by Persistence Market Research presents interesting facets of the  global cloud-based drug discovery platform market  and provides value forecasts for an eight year period from 2017 to 2025. The report titled  'Cloud-based Drug Discovery Platform Market: Global Industry Analysis ( 2012 - 2016) and Forecast (2017–2025) '  is a comprehensive take on the global cloud-based drug discovery platform market and highlights the different factors anticipated to impact market revenue growth during the said period.

According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/11020

Company Profiles

  • IBM Corporation
  • Accenture PLC
  • Tata Consultancy Services Limited
  • SAS Institute Inc.
  • BioXcel Corporation
  • Cloud Pharmaceuticals Inc.
  • WuXi AppTec (Sanghai) Co. Ltd.
  • Dassault System
  • Acelot, Inc.
  • Others.

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

  • Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency
  • Traction in the adoption of machine learning and artificial intelligence for drug discovery
  • Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players

Get To Know Methodology of Report @  https://www.persistencemarketresearch.com/methodology/11020

Growth challenges

  • Concerns regarding infrastructure compatibility issues
  • Issues pertaining to interoperability of applications with devices

Market trends

  • Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North America region
  • Rising adoption of cloud-based mobile applications for collaborative drug discovery

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a  CAGR of 13.4%.

Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of  US $ 1,247.8 Mn  by the end of 2025.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period.

The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high YoY growth rates throughout the forecast period .

In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a  CAGR of 16.7%  during the forecast period.

]]>
The Trauma Fixation Devices Market To Prosper On A Healthy Note Between 2025 Wed, 13 Jan 2021 14:36:17 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683443.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683443.html persistencemarketresearch persistencemarketresearch Global  trauma fixation devices market  is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand for trauma fixation devices in hospital's emergency departments, as well as outpatient surgery.

Increasing cases of accidents and other trauma-related indications are likely to provide a major boost for this market over the forecast period. In this newly published report titled,  "Trauma Fixation Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),"  Persistence Market Research has not only offered the forecast analysis but has also presented the historical data of the global trauma fixation devices market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/18556

Company Profiles 

  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson and Johnson (DePuy Synthes)
  • Wright Medical Group, Inc.
  • Orthofix International N.V.
  • Cardinal Health Inc
  • Medtronic
  • Integra LifeSciences
  • Double Medical Technology Inc
  • Citieffe S.R.L
  • B. Braun Melsungen AG
  • Arthrex Inc.
  • Acumed LLC
  • Conmed Corporation
  • Smith & Nephew
  • Others.

According to the report, this market is likely to grow from US$ 1,753.6 Mn in 2016 to US$ 3,333.1 Mn by 2025 end, registering a healthy CAGR of 7.4% during the period of eight years, i.e. 2017-2025.

Global Trauma Fixation Devices Market: Trends

  • The incorporation of technology for the treatment of trauma and introduction of platform system for shoulder arthroplasty
  • International collaboration to expand domestic reach and increasing popularity of medical tourism
  • Technologically advanced products replacing traditional orthopedic devices, improved patient outcome and reduction in surgical time
  • Domestic companies’ gaining age in the developing region’s trauma fixation devices market
  • Use of robotic technology during surgery to avoid complications
  • Incorporating technology to enable patient-centric approach

Global Trauma Fixation Devices Market: Forecast by Fixation Type

This segment includes two key segments- internal fixation and external fixation. Internal fixation is the largest segment in global trauma fixation devices market, which is estimated to represent US$ 1,582.5 Mn, or 84.3% share of the total market in 2017 and US$ 2,889.5 Mn, or 86.7% by 2025 end, expanding at CAGR of 7.8% over the forecast period of 2017–2025.

Internal fixation dominated the global trauma fixation devices market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. This segment is expected to be the most lucrative among all end users, with attractiveness index of 1.8.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/18556   

Global Trauma Fixation Devices Market: Forecast by End User

End user segment is consists of hospital and ambulatory surgical centers. Hospital is the largest segment in global trauma fixation devices market, which is estimated to represent  US $ 1,383.2 Mn  of the total market in 2017 and is anticipated to be valued at  US $ 2,537.5 Mn by 2025 end , expanding at CAGR of 7.9% over the forecast period of 2017–2025.

While, ambulatory surgery centers segment is expected to be the second largest market for trauma fixation devices market, with market share index of 0.4.

Global Trauma Fixation Devices Market: Forecast by Product Type

On the basis of product type this market is segmented into metal plates and screws, pins / wires, nails and rods, circular fixator, hybrid fixator, unilateral fixator. With 42.9% revenue share in 2017, metal plates and screws is expected to be the most lucrative among all end users, with attractiveness index of 2.8.

On the other hand the pins / wires segment is expected to be the second dominant product type in the trauma fixation devices market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/18556

Global Trauma Fixation Devices Market: Regional Forecast and Analysis

Five regions are covered in this reports namely, North America, Latin America, Europe, APAC and MEA. Europe is the largest region in trauma fixation devices market, which is estimated to represent  US $ 1,013.0 Mn , or 54% share of the total market in 2017 and is projected to reach to  US $ 1,818.2 Mn , or 54.6%, expanding at CAGR of 7.6% over the forecast period of 2017–2025.

Europe dominated the global trauma fixation devices market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

]]>
The Surgical Gowns Market To Knock The “Growth” Door Between 2025 Wed, 13 Jan 2021 14:35:55 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683442.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683442.html persistencemarketresearch persistencemarketresearch The global demand for surgical gowns continues to be on a high, owing to the increasing number of surgeries being carried out on a daily basis in hospitals across the globe. In an attempt to study the performance of the global surgical gowns market, Persistence Market Research has recently published a new report titled  "Surgical Gowns Market: Global Industry Analysis and Forecast (2017–2025),"  which analyzes the global surgical gowns market and presents useful insights over an eight year period from 2017 to 2025.

One of the key observations of the report centers on the global awareness of Hospital Acquired Infections (HAIs) that is working in favor of the increasing adoption of surgical gowns, both by patients and surgeons. The report also presents insights into the trends likely to govern the market such as innovations by surgical gowns manufacturers in the fabric used to manufacture surgical gowns.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/17143

Company Profiles

  • Ahlstrom-Munksjö
  • Alan Medical
  • Cardinal Health, INC.
  • FULLSTAR NON-WOVEN PRODUCTS CO. LTD.
  • Garmex Andrzej Jafiszow, Wojciech Kaminski sp. J.
  • GrupA Medical Products
  • Halyard Health, Inc.
  • Hogy Medical Co. Ltd.
  • Johnson & Johnson
  • Lohmann & Rauscher GmbH & Co. KG
  • Medline Industries, Inc.
  • Molnlycke Health Care
  • NUREL MEDIKAL SANAYI VE TICARET ANONIM SIRKETI
  • Paul Hartmann AG
  • PRIMED Medical Products, Inc.
  • Priontex (PTY) LTD
  • Surgiene Healthcare (India) Pvt. Ltd.
  • TIDI Products LLC
  • Vygon S.A.
  • 3M Company
  • Others

Global Surgical Gowns Market: Overview & Forecast

The surgical gowns market is witnessing significant growth owing to better healthcare infrastructure especially in developed regions such as North America and Europe.

The developing countries in the Asia Pacific are likely to exhibit the highest growth rate in the global surgical gowns market, owing to a high rate of population growth across the region. Persistence Market Research estimates the global surgical gowns market to reach a valuation of US$ 1,703.9 Mn by 2025 end from an estimated US$ 1,123.0 Mn in 2017, resulting in a CAGR of 5.3% over the period of forecast.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/17143

Global Surgical Gowns Market: Segmental Forecast

The global surgical gowns market is segmented on the basis of Product Type into Disposable and Reusable surgical gowns. The disposable segment is the largest among the product types, with a projected 71.4% market share by the end of 2025.

The disposable surgical gowns segment is expected to represent an absolute $ opportunity of US$ 40.7 Mn in 2018 over 2017, also creating an incremental opportunity of US$ 580.9 Mn between 2017 and 2025.

The global surgical gowns market is segmented on the basis of End User into Hospitals, Clinics & Trauma Centers, and Ambulatory Surgical Centers.

Hospitals will continue to dominate the global market in terms of value throughout the forecast period, growing from an estimated  US $ 731.6 Mn in 2017 to US $ 1,113.9 Mn  by the end of the forecast period in 2025, registering a  CAGR of 5.4% . Ambulatory surgical centers will lead the market in terms of CAGR growth though,  recording 6.0% during  the forecast period.

The global surgical gowns market is segmented on the basis of  Distribution Channel  into Online Sales, Retail Pharmacies, and Direct Sales. Direct sales is the largest segment in this category, which is estimated to represent US $ 970.7 Mn, or 86.4% share of the total market in 2017 in terms of revenue and expanding at a CAGR of 5.5% over the forecast period.

The direct sales distribution channel segment is expected to represent an absolute $ opportunity of US $ 48.5 Mn in 2018 over 2017, also creating an incremental opportunity of US $ 518.6 Mn between 2017 and 2025.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/17143

Persistence Market Research has tracked the global surgical gowns market across the key  Regions  of North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.

North America and Asia Pacific are the largest regional markets in the global surgical gowns market, with North America slated to hold a market share of almost 22% and Asia Pacific a share of 30% in the global market by the end of 2025.

The number of surgeries performed per year is the highest in North America and hence North America is expected to continue to generate maximum revenue in the global surgical gowns market. The Asia Pacific surgical gowns market will grow at  7.1% CAGR  during the forecast period while North America will register the lowest regional  CAGR of 3.3%.

]]>
The Advanced Medical Nutrition Market To Revitalize Post Covid-19 (2025 Onwards) Wed, 13 Jan 2021 14:35:32 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683441.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683441.html persistencemarketresearch persistencemarketresearch " Medical Nutrition Market:  Global Industry Analysis (2012-2016) and Forecast 2017–2025,"  a new report by Persistence Market Research concentrates on the parenteral nutrition segment and its overall performance in the  global medical nutrition market  for the duration of eight years. The report segments the global parenterally administered medical nutrition market on the basis of product type, distribution channel, nutrition type and region.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/16588

Company Profiles

  • Allergan
  • Baxter International Inc.
  • Braun Melsungen AG.
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • Sanofi
  • Mead Johnson & Company, LLC
  • Sichuan Kelun Pharmaceutical Company Limited
  • Otsuka Pharmaceuticals Co., Ltd.
  • Grifols S.A.
  • Abbott Laboratories
  • Danone Nutricia
  • Demo S.A. Pharmaceutical Industry
  • Others.

Global Medical Nutrition Market: Forecast by Product Type

This segment is divided into Amino Acid Solution, Multiple Vitamins and Antioxidants, Lipid Emulsion, Trace Elements, 2C Bags, and 3C Bags. The Amino Acid Solution segment dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Amino Acid Solution segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/16588

Global Medical Nutrition Market: Forecast by Distribution Channel

Hospital Pharmacies, Retail Pharmacies, Compound Pharmacies are the sub-segments in this category. The Retail Pharmacies segment is expected to be the second most lucrative market in the global parenteral nutrition market by distribution channel, with an attractiveness index of 0.5 during the forecast period.

The Retail Pharmacies segment is estimated to  account for 13.1%  value share in 2017. Hospital Pharmacies will hold the largest market share of more than 65% throughout the forecast period.

Global Medical Nutrition Market: Forecast by Nutrition Type

The global parenterally administered medical nutrition market is estimated to represent incremental opportunity of  US $ 2,577.4 Mn  between 2017 and 2025. The market is expected to grow from  US $ 3,468.9 Mn in 2017 to US $ 6,046.3 Mn by 2025 end . This represents a  CAGR of 7.2%  over the forecast period.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/16588

Global Medical Nutrition Market: Forecast by Region

The North America region dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. North America is the most attractive regional market, with an attractiveness index of 2.2 over the forecast period.

Revenue from the North America regional market is anticipated to increase at a  CAGR of 8.7%  over 2017–2025, to reach  US $ 2,365.9 Mn by 2025.

]]>
The Europe Cryochambers Market To Witness A Healthy Reverberation Between 2026 Wed, 13 Jan 2021 14:35:10 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683440.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683440.html persistencemarketresearch persistencemarketresearch Proactive lifestyle and fluctuating temperatures experienced across the European region are, at many times, the cause of several chronic disorders.

Growing incidence of chronic medical conditions, coupled with distress caused due to unfavorable temperature changes, continue to stimulate the adoption of cryotherapy in Europe. Persistence Market Research's recent report on  Europe's cryochambers market  delivers insights on how the temperature-based medical therapy is picking up momentum.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/14374

Company Profiles

  • Zimmer MedizinSysteme GmbH
  • KrioSystem Sp. Zoo
  • Air Products and Chemicals, Inc.
  • METRUM CRYOFLEX Sp. Z oo, Sp. K.
  • Novotech SRO
  • CryoAction Limited
  • JUKA SP. ZOO SP.K.
  • Cryosense
  • CRYO Science
  • Others
Decreasing inflammation, increasing metabolism and reduction of chronic pain & fatigue are some of the essential benefits of cryotherapy that will continue to compel the use of cryochambers in Europe. The report estimates that a little over US$ 65 Mn worth of cryochambers are expected to be sold in Europe by the end of 2026.

In 2016, the Europe crychambers market was valued at US$ 43 Mn, and is anticipated to register a steady growth at 5.4% CAGR during the forecast period. Demand for cryochambers is also expected to rise in Europe, owing to improving outcomes of cryotherapy and prevalence of health trends.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14374

In order to boost personal happiness and increase performance levels, urban consumers in European countries will be opting for cryotherapy as a remedy to their hectic livelihood.

In the report, titled “ Cryochambers Market: Europe Industry Analysis and Forecast, 2016-2026 ,” Germany, France, Poland and the UK are projected to be at the forefront of Europe's cryochambers market. These countries will continue to dominate the market with a revenue share of more than 10%.

The report further reveals that throughout the forecast period, the consumption of multiple-person cryochamber will be considerable higher than individual cryochambers. Over two-third of Europe's cryochamber revenues will be accounted by sales of multiple-person units across the region.

The report estimates that in 2016, more than 200 units of cryochambers were sold across Europe, anticipating that this number could  rise at 6.3% CAGR  and reach 336 by the end of 2026. Almost every boon attained from undertaking cryotherapy helps in rejuvenating ones' personal appearance, which is why the report expects higher consumption of cryochambers by dermatologists for cosmetic applications.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/14374

Through 2026, every other cryochamber sold in Europe is likely to be used for dermatology or cosmetic applications. The need for cryochambers will also gain traction for sports medicine & pain management applications.

In Europe, the largest end-user of cryochambers is a fitness center or a beauty spa. Together, fitness centers and beauty spas spanned across European countries are presently accounting for more than 35% of market value. In the years to come, the demand for cryochambers will also grow vigorously in European sports clubs and athletic associations.

]]>
The US Polycystic Ovarian Syndrome Treatment Market To Settle Down At A CAGR Of 3.9% Tue, 12 Jan 2021 20:50:09 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683289.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683289.html persistencemarketresearch persistencemarketresearch Prevalence of endocrine diseases in the US is on a rise as the country's urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and  polycystic ovarian syndrome (PCOS)  continues to alarm public health authorities across the US.

Measures undertaken by non-profit organizations and US health regulatory bodies are promoting the awareness of PCOS treatments. Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical needs of people suffering from such complications.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/14317

Company Profiles 

  • Sanofi
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Merck KGaA
  • AstraZeneca

Get To Know Methodology of Report @  https://www.persistencemarketresearch.com/methodology/14317

Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research's recent publication estimates that the  US $ 230 Mn PCOS  treatment market in the US will exhibit a moderate value  CAGR of 3.9%  to reach  US $ 313.2 Mn  by the end of 2024.

The foremost growth inhibitor for polycystic ovary syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment.

Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.

Titled as " Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024 ," the report projects that in 2016, more than  US $ 66 Mn  worth of oral contraceptive drugs were consumed in the  US polycystic ovary syndrome treatment market .

Access Full Report @  https://www.persistencemarketresearch.com/checkout/14317

Through 2024, oral contraceptives will be exhibiting a steady revenue growth at  5.3% CAGR , and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach  US $ 49 Mn by 2024-end .

More than 47% of US polycystic ovary syndrome treatment market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly  US $ 150 Mn  worth of PCOS drugs will be sold through these pharmacies.

Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value  CAGR of 4.6% , higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.

]]>
The Intra Operative Imaging Market To Grow At A Splendid CAGR Of 9.4% Tue, 12 Jan 2021 20:49:47 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683288.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683288.html persistencemarketresearch persistencemarketresearch Persistence Market Research has recently published its report on the global market for intraoperative imaging, excerpts from which predict the market to be presently valued at US $ 513.9 million. According to the report, the demand for intraoperative imaging will keep surging on the grounds of increasing adoption of minimally-invasive surgeries and remarkable progress witnessed in the field of diagnostic imaging for neurosurgeries.

The world's leading medical research institutes are also taking big leaps towards development of advanced imaging technologies. By the end of 2024, the global  intraoperative imaging market  will expand at a  CAGR of 9.4%  and bring in an estimated  US $ 1,145.3 million  in revenues.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/4517

Company Profiles

  • Brainlab AG
  • NeuroLogica Corporation
  • GE Healthcare
  • IMRIS, Inc.
  • Philips Healthcare
  • Medtronic PLC
  • Siemens AG

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4517

Intraoperative imaging systems are gaining popularity in the global healthcare industry as notable industry leaders are building strategic collaborations & partnerships to foray into this market. The global intraoperative imaging market continues to remain uncharted as patients as well as medical professionals from around the world aren't entirely aware of the diagnostic benefits of intraoperative imaging, compared to other existing imaging technologies. After gaining acceptance in hospitals and diagnostic centers across the globe, intraoperative imaging devices can be further evolved to include features such as real-time imaging.

Nearly three-fourth of global intraoperative imaging revenues are concentrated in the sales of intraoperative imaging systems. The report reveals that throughout the forecast period, intraoperative imaging services will lose out on revenue share, and be valued at a little less than  US $ 300 million by 2024-end.  Also, the use of intraoperative imaging systems will primarily be in the field of neurosurgery.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/4517

Based on the research findings, neurosurgical intervention will be the largest application of intraoperative imaging in the world. By the end of 2024, nearly US $ 400 million worth of intraoperative imaging systems will be globally consumed by neurosurgical imaging procedures. Additionally, the demand for intraoperative imaging will be fairly high in orthopedic and cardiovascular diagnosis.

In the report titled “ Intraoperative Imaging Market: Global Industry Analysis and Forecast, 2016-2024 ,” hospitals are observed to be the largest end-users of intraoperative imaging. While hospitals will undoubtedly dominate the global intraoperative imaging market revenues, cancer research institutes are also expected to increase their expenditure on intraoperative imaging devices.

With the help of intraoperative imaging systems, these institutes are striving to improve the diagnostic & imaging approach for treatment of various cancers. In 2016, nearly US $ 180 million worth of intraoperative imaging systems were consumed by global cancer research institutes.

]]>